Get to know our clinical trials

Clinical trial Non-vitamin K antagonist oral anticoagulants in patients with rapid atrial rate episodes

THE OBJECTIVE OF THE NOAH STUDY IS TO DEMONSTRATE THAT LONG-TERM ORAL ANTICOAGULATION WITH EDOXABAN IS SUPERIOR TO THE CURRENT STRATEGY OF NOT ADMINISTERING ORAL ANTICOAGULATION IN PATIENTS WITH EFAR WHO PRESENT TWO ADDITIONAL RISK FACTORS FOR STROKE.

Status
In recruitment
headquarters
Madrid

Technical Summary

  • CLINICAL TRIAL NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS IN PATIENTS WITH RAPID ATRIAL RATE EPISODES
  • Code EudraCT: 2015-003997-33
  • Protocol number: NOAH-AFNET
  • Promoter: Kompetenznetz Vorhofflimmern e.V. (AFNET)
  • Link to Clinical Trials

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.